What is the standard of care for metastatic Melanoma according to NCCN guidelines

Standard of Care for Metastatic Melanoma (Stage 4)

Based on the NCCN Guidelines for Patients: Melanoma (2025), here's what you need to know about how metastatic melanoma is typically treated:

Primary Treatment Approach: Systemic Therapy

Systemic therapy is the preferred initial treatment for metastatic melanoma. This means medications that travel through your bloodstream to reach cancer cells throughout your body, rather than treating just one specific area.

The main types of systemic therapy used include:

1. Immunotherapy (Checkpoint Inhibitors)

These are often the first-line treatments because they help your immune system recognize and attack cancer cells:

• Pembrolizumab (Keytruda) - blocks PD-1 checkpoint proteins
• Nivolumab (Opdivo) - also blocks PD-1 checkpoint proteins
• Ipilimumab - blocks CTLA-4 checkpoint proteins

According to NCCN Guidelines, these checkpoint inhibitors work by blocking proteins that tumor cells use to "hide" from your immune system. By removing this shield, your T cells (immune cells) can recognize and kill the cancer cells.

2. Targeted Therapy

If your melanoma has a BRAF V600 mutation (a specific genetic change found in some melanomas), you may receive:

• Dabrafenib/trametinib - targets the BRAF mutation directly

Your doctor will test for this mutation to determine if targeted therapy is an option for you.

Additional Treatment Options

Beyond systemic therapy, metastatic melanoma may also be treated with:

• Surgery - to remove specific tumors if they're causing problems
• Radiation therapy - including specialized techniques like stereotactic radiosurgery (SRS) for brain metastases
• Intralesional T-VEC injections - a virus-based therapy injected directly into tumors
• Supportive/palliative care - to manage symptoms and side effects

How Doctors Decide Your Treatment Plan

According to NCCN Guidelines, your oncologist will consider:

1. Where the cancer has spread (brain, lungs, liver, etc.)
2. Your BRAF mutation status (whether you have this genetic change)
3. Your overall health and ability to tolerate treatment
4. Previous treatments you've received
5. Your treatment goals (extending survival vs. managing symptoms)

Important Questions to Ask Your Care Team

To engage in shared decision-making about your specific treatment plan:

1. "Does my melanoma have a BRAF mutation, and what does that mean for my treatment options?"
2. "Which systemic therapy do you recommend for me, and why?"
3. "What are the expected side effects, and how will we manage them?"
4. "Are there clinical trials available that might be appropriate for my situation?"
5. "How will we monitor whether the treatment is working?"
6. "What is the treatment schedule, and how long will I receive this therapy?"

Key Takeaway

The NCCN Guidelines emphasize that metastatic melanoma treatment is individualized. While systemic immunotherapy is the preferred starting point for most patients, your specific treatment plan depends on your unique cancer characteristics, genetic testing results, and overall health. Your oncologist will determine the most appropriate approach for YOUR case based on the complete clinical picture.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.